Skip to main content
SpringerLink
Log in

Nutritional Issues in Vasculitis

  • Chapter
Nutrition and Rheumatic Disease

Part of the book series: Nutrition and Health ((NH))

  • 1623 Accesses

Summary

• Gastrointestinal involvement is common in systemic vasculitis.

• Chronic systemic inflammation is common in vasculitis and frequently leads to weight loss and cachexia.

• Immunosuppressive medications can cause gastrointestinal toxicity.

• There is little evidence of any dietary manipulations or supplementations having any impact on the course of vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Frankel SK, Sullivan EJ, Brown KK. Vasculitis: Wegener’s granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa and Takayasu’s arteritis. Crit Care Clinics 2002;18: 855–879.

    Article  Google Scholar 

  2. Saleh A, Stone JH. Classification and diagnostic criteria in systemic vasculitis. Best Pract Res Clin Rheumatol 2005;19(2):209–221.

    Article  PubMed  Google Scholar 

  3. Buhaescu I, Covic A, Levy J. Systemic vasculitis: still a challenge. Am J Kidney Dis 2005;46: 173–185.

    Article  PubMed  Google Scholar 

  4. Hellmich B, Gross WL. Difficult to diagnose manifestations of vasculitis: Does an interdisciplinary approach help? Best Pract Res Clin Rheumatol 2005;19(2):243–262.

    Article  PubMed  Google Scholar 

  5. Lie JT. Vasculitis simulators and vasculitis look-alikes. Curr Opin Rheumatol 1992;4:47.

    Google Scholar 

  6. O’Keefe ST, Woods BO, Breslin DJ, et al. Blue toe syndrome. Causes and management. Arch Intern Med 1992;152:2197.

    Google Scholar 

  7. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg- Strauss syndrome: a prospective study of 342 patients. Medicine 1996;75:17–28.

    Article  PubMed  CAS  Google Scholar 

  8. Griffin J. Vasculitis neuropathies. Rheum Dis Clin North Am 2001;27:751–760.

    Article  PubMed  CAS  Google Scholar 

  9. Moore PM, Fauci AS. Neurologic manifestations of systemic vasculitis: a retrospective and prospective study of clinicopathologic features and responses to therapy in 25 patients. Am J Med 1981;71:517–524.

    Article  PubMed  CAS  Google Scholar 

  10. Said G, Lacroi-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinical pathologic study. Ann Neurol 1988;23:461–465.

    Article  PubMed  CAS  Google Scholar 

  11. Levine SM, Hellman DB, Stone JH. Gastrointestinal involvement in polyarteritis nodosa (1986–2000); presentation and outcomes in 24 patients. Am J Med 2002;112:386–391.

    Article  PubMed  Google Scholar 

  12. Holsinger DR, Osmundson PJ, Edwards JE. The heart in periarteritis nodosa. Circulation 1962;25: 610–618.

    PubMed  CAS  Google Scholar 

  13. Schrader ML, Hochman JS, Bulkley BH. The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 1985;109:1353–1359.

    Article  PubMed  CAS  Google Scholar 

  14. Lhote F, Guilliven L. Polyarteritis nodosa, microscopic polyangiitis, Churg Strauss syndrome: clinical aspects and treatment. In Hunder GG, ed. Rheum Dis Clinics of North America, Saunders, Philadelphia, PA, 1995, pp. 911–947.

    Google Scholar 

  15. Fye KH, Becker MJ, Theofilopoulos AN, et al. Immune complexes in hepatitis B antigen-associated periarteritis nodosa: detection by antibody independent cell-mediated cytotoxicity and the Raji cell assay. Am J Med 1977;62:783–791.

    Article  PubMed  CAS  Google Scholar 

  16. Tsukada N, Koh C, Owa M, et al. Chronic neuropathy associated with immune complexes of hepatitis B virus. J Neurol Sci 1983;61:193–211.

    Article  PubMed  CAS  Google Scholar 

  17. Carson CW, Conn AJ, Czaja AJ, et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheum 1993;20:304–309.

    PubMed  CAS  Google Scholar 

  18. Cid MC, Grau JM, Casademont J, et al. Immunohistochemical characterization of inflammatory cells and immunologic activation markers in muscle and nerve biopsy specimens from patients with polyarteritis nodosa. Arthritis Rheum 1994;37:1055–1061.

    Article  PubMed  CAS  Google Scholar 

  19. Gayraud M, Guillevin L, Toumelin P, et al. Long-term follow-up of Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Arthritis Rheum 2001;44(3):666–675.

    Article  PubMed  CAS  Google Scholar 

  20. Guillevin L, Mahr A, Cohen P, et al. Short term corticosteroids then lamivudine and plasma exchanges to treat Hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004;51(3):482–487.

    Article  PubMed  CAS  Google Scholar 

  21. Guillevin L, Fain O, Lhote F, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective randomized trial in 78 patients. Arthritis Rheum 1992;35:208–215.

    Article  PubMed  CAS  Google Scholar 

  22. Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970;1003:283.

    Google Scholar 

  23. Luqmani R, Watts RA, Scott DGI, et al. Treatment of vasculitis in rheumatoid arthritis. Ann Intern Med 1994;145:566–576.

    CAS  Google Scholar 

  24. Mertz LE, Conn DL. Vasculitis associated with malignancy. Curr Opin Rheumatol 1992;4:39–46.

    PubMed  CAS  Google Scholar 

  25. Somer T, Finegold SM. Vasculitides associated with infections, immunizations, and antimicrobrial drugs. Clin Inf Dis 1995;20:1010–1036.

    CAS  Google Scholar 

  26. Falk RJ, Nachman PH, Hogan SL, et al. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol 2000;20(3):233.

    Google Scholar 

  27. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis. Arthritis Rheum 1999;42:421–430.

    Article  PubMed  CAS  Google Scholar 

  28. Gaskin G, Jayne D. Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis. J Am Soc Nephrol 2002;13(suppl:S2A–S3A.

    Google Scholar 

  29. Jayne DRW, Chapel H, Adu D, et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Q J Med 2000;93:433–439.

    CAS  Google Scholar 

  30. Guillevin L, Guittard T, Bletry O, et al. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung 1987;165:165–172.

    Article  PubMed  CAS  Google Scholar 

  31. Guillevin L, Cohen P, Gayraud M, et al. Churg- Strauss syndrome: clinical study and long-term follow-up in 96 patients. Medicine (Baltimore) 1999;78:26–37.

    Article  CAS  Google Scholar 

  32. Guillevin L, Visser H, Noel LH, et al. Antineutrophilic cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients. J Rheumatol 1993;20:1345–1349.

    PubMed  CAS  Google Scholar 

  33. Solans R, Bosch JA, Perez-Bocanegra C, et al. Churg-Strauss syndrome: outcome and longterm follow-up of 32 patients. Rheumatology 2001;40:763–771.

    Article  PubMed  CAS  Google Scholar 

  34. Sable-Fourtassou, Cohen P, Mahr A, et al. Antineutrophil cytoplasmic antibodies and Churg-Strauss syndrome. Ann Intern Med 143:632–638, 2005.

    Google Scholar 

  35. Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995;47:618–623.

    Article  PubMed  CAS  Google Scholar 

  36. Bombardieri S, Paoletta P, Ferri C, et al. Lung involvement in essential mixed cryoglobulinemia. Am J Med 1979;66:748–756.

    Article  PubMed  CAS  Google Scholar 

  37. Caniatti LM, Tugnoli V, Eleopra R, et al. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory, and neurophysiological study. J Periph Nerv Syst 1996;1:131–138.

    CAS  Google Scholar 

  38. Gomez-Tello V, Onoro-Canaveral JJ, de la Casa Monje RM, et al. Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus related mixed cryoglobulinemia. Intensive Care Med 1999;25(3):319.

    Google Scholar 

  39. Agnello V, Ghung RT, Kaplan LM. A role for Hepatitis C virus in type II cryoglobulinemia. N Engl J Med 1992;327:1490.

    Google Scholar 

  40. Lamprecht P, Moosig F, Gause A, et al. Immunologic and clinical follow-up of hepatitis C virus associated cryoglobulinemic vasculitis. Ann Rheum Dis 2001;60:385–390.

    Article  PubMed  CAS  Google Scholar 

  41. Guillevin L, Pagnoux C. Indications of plasma exchanges for systemic vasculitides. Ther Apher Dial 2003;7(2):155–160.

    Article  PubMed  Google Scholar 

  42. Rieu V, Cohen P, Andre MH, et al. Characteristics and outcome of 49 patients with symptomatic cryoglobulinemia. Rheumatology (Oxford) 2002;41:290–300.

    Article  CAS  Google Scholar 

  43. Godman GC, Churg J. Wegener’s granulomatosis: pathology and review of the literature. Arch Pathol 1954;58:533–553.

    CAS  Google Scholar 

  44. Fauci AS, Wolff SM. Wegener’s granulomatosis: studies in eighteen patients and a review of the literature. Medicine 1973;52(6):535–561.

    Article  PubMed  CAS  Google Scholar 

  45. Wolff SM, Fauci AS, Horn RG, et al. Wegener’s granulomatosis. Ann Intern Med 1974;81(4): 513–525.

    PubMed  CAS  Google Scholar 

  46. Popa ER, Tervaert JW, et al. The relationship between Staphylococcus aureus and Wegener’s granulomatosis: current knowledge and future directions. Int Med 2003;42(9):771–780.

    Article  CAS  Google Scholar 

  47. Kerr GS, Fleisher TA, Hallahan CW, et al. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum 1993;36(3):365–371.

    Article  PubMed  CAS  Google Scholar 

  48. Boomsa MM, Stegeman CA, van der Leij MJ, et al. Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43(9):2025–2033.

    Article  Google Scholar 

  49. Falk RJ, Jennette JC. ANCA are pathogenic—oh yes they are! J Am Soc Nephrol 2002;13(7): 1977–1979.

    PubMed  Google Scholar 

  50. Fauci AS, Haynes BF, Katz P, et al. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98(1):76–85.

    PubMed  CAS  Google Scholar 

  51. Schramm VL Jr, Myers EN, Rogerson DR. The masquerade of vasculitis: head and neck diagnosis and management. Laryngoscope 1978;88(12):1922–1934.

    Article  PubMed  Google Scholar 

  52. Goldenberg DL, Goodman ML. Case 26–1985. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med 1985;312:1695–1697.

    Article  Google Scholar 

  53. Harrington JT, McCluskey RT. Case 24–1979. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med 1979;300:1378–1380.

    Article  Google Scholar 

  54. McDonald TJ, DeRemee RA: Wegener’s granulomatosis. Laryngoscope 1983;93(2):220–231.

    Article  PubMed  CAS  Google Scholar 

  55. Langford CA, Sneller MC, Hallahan CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s Granulomatosis. Arthritis Rheum 1996;39(10): 1754–1760.

    Article  PubMed  CAS  Google Scholar 

  56. Bernhard JD, Mark EJ. Case 17–1986. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med 1986;314:1170–1173.

    Article  Google Scholar 

  57. Hoffman G, Kerr G, Leavitt R. Wegener’s Granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488–498.

    PubMed  CAS  Google Scholar 

  58. Lynch JP, Matteson E, McCune WJ. Wegener’s granulomatosis: evolving concepts. Medical Rounds 1989;2:67.

    Google Scholar 

  59. Regan M, Hellmann D, Stone J. Treatment of Wegener’s Granulomatosis. Rheum Dis Clinics of North America 2001;27(4):863–886.

    Article  CAS  Google Scholar 

  60. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis. Long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021–1032.

    Article  PubMed  CAS  Google Scholar 

  61. Ognibene, FP, Shelhamer JH, Hoffman, GS, et al. Pneumocystis carinii pneumonia: A major complication of immunosuppressive therapy in patients with Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151:795–799.

    PubMed  CAS  Google Scholar 

  62. Calabrese LH, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 1992;33(8):1108–1113.

    Article  Google Scholar 

  63. Merkel P. Drug-induced vasculitis. Rheum Dis Clinics of North America 2001;27(4):849–862.

    Article  CAS  Google Scholar 

  64. Bonilla MA, Dale D, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor in patients with severe congenital neutropenias. Br J Hematol 1994;88(4):723–730.

    CAS  Google Scholar 

  65. Blumberg S, Bienfang D, et al. A possible association between influenza vaccination and small vessel vasculitis. Arch Intern Med 1980;140(6):847–848.

    Article  PubMed  CAS  Google Scholar 

  66. Ascherio A, Zhang SM, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344(5):327–332.

    Article  PubMed  CAS  Google Scholar 

  67. Alexander EL. Neurologic disease in Sjogrens syndrome: mononuclear inflammatory vasculopathy affecting the central/peripheral nervous system and muscle. Rheum Dis Clin North Am 1993;19: 869–908.

    PubMed  CAS  Google Scholar 

  68. Neamtu L, Belmont M, Miller DC, et al. Rheumatoid disease of the central nervous system with meningeal vasculitis presenting with seizure. Neurology 2001;56(6):814–815.

    PubMed  CAS  Google Scholar 

  69. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases. Semin Arthritis Rheum 1979;8:212–221.

    Article  PubMed  CAS  Google Scholar 

  70. Siva A. Vasculitis of the nervous system. J Neurol 2001;248:451–468.

    Article  PubMed  CAS  Google Scholar 

  71. Younger DS, Calabrese LH, Hays AP. Granulomatous angiitis of the nervous system. Neurol Clin 1997;15:821–834.

    Article  PubMed  CAS  Google Scholar 

  72. Calabrese LH, Furlan AJ, Gragg LA, et al. Primary angiitis of the central nervous system (PACNS): a reappraisal of diagnostic criteria and revised clinical approach. Cleve Clin J Med 1992;293–306.

    Google Scholar 

  73. Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 1995;222:662–667.

    Google Scholar 

  74. Harris K, Tram D, Skekels W, et al. Diagnosing intracranial vasculitis: the roles of MRI and angiography. Am J Neuroradiol 1994;15:317–330.

    PubMed  CAS  Google Scholar 

  75. Vanderzant C, Bomberg M, MacGuire A, et al. Isolated small vessel angiitis of the central nervous system. Arch Neurol 1988;45:683–687.

    PubMed  CAS  Google Scholar 

  76. Lie JT. Primary (granulomatous) angiitis of the central nervous system: a clinical pathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992;23:164–1717.

    Article  PubMed  CAS  Google Scholar 

  77. Hajj-Ali RA, Ghamande S, Calabrese LH, et al. Central nervous system vasculitis in the intensive care unit. Crit Care Clin 2002;18:897–914.

    Article  PubMed  Google Scholar 

  78. Weyand CM, Goronzy JJ. Giant cell arteritis and polymyalgia rheumatica. Ann Int Med 2003; 139(6):505–515.

    Google Scholar 

  79. Calamia KT, Hunder GG. Clinical manifestations of giant cell (temporal) arteritis. Clin Rheum Dis 1980;6:389–403.

    Google Scholar 

  80. Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42(2):311–317.

    Article  PubMed  CAS  Google Scholar 

  81. Kaiser M, Weyand C, Bjornsson J, Goronzy JJ. Platelet derived growth factor, intimal hyperplasia and ischeamic complications in GCA. Arthritis Rheum 1998;41:623–633.

    Article  PubMed  CAS  Google Scholar 

  82. Chan CC, O’Day J. Oral and intravenous steroids in giant cell arteritis. Clin Experiment Ophthalmol 2003;31(3):179–182.

    Article  PubMed  Google Scholar 

  83. Jover JA, Hernandez-Garcia C, Morado IC, et al. Combined treatment of giant cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;134(2):106–114.

    CAS  Google Scholar 

  84. Hoffman GC, Cid MC, Hellman DB, et al. A multicenter, randomized, double- blind placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46(5):1309–1318.

    Article  PubMed  CAS  Google Scholar 

  85. Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50(4): 1332–1337.

    Article  PubMed  CAS  Google Scholar 

  86. Evans JM, Bowles CA, Bjornsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. Arthritis Rheum 1994;37(10):1539–1547.

    Article  PubMed  CAS  Google Scholar 

  87. Kerr GS, Hallahan CW, Giordana J, et al. Takaysu arteritis. Ann Int Med 1994;120:919–929.

    PubMed  CAS  Google Scholar 

  88. Vanoli M, Daina E, Salvarani C, et al. Takaysu’s arteritis: A study of 104 Italian patients. Arthritis Rheum 2005;15(1):100–107.

    Article  Google Scholar 

  89. Chugh KS, Sakhuja V. Takayasu’s arteritis as a cause of renovascular hypertension in Asian countries. Am J Nephrol 1992;12:1–8.

    Article  PubMed  CAS  Google Scholar 

  90. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis 2004;63(8):995–1000.

    Article  PubMed  CAS  Google Scholar 

  91. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005;17(1):9–15.

    Article  PubMed  Google Scholar 

  92. Hoffman GS, Leavitt RY, Kerr GS, et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994;37(4):578–582.

    Article  PubMed  CAS  Google Scholar 

  93. Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50(7):2296–2304.

    Article  PubMed  CAS  Google Scholar 

  94. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005;17(1):16–24.

    Article  PubMed  CAS  Google Scholar 

  95. Marshall SE. Behcet’s disease. Best Pract Res Clin Rheumatol 2004;18(3):291–311.

    PubMed  CAS  Google Scholar 

  96. Suzuki Kurokawa M, Suzuki N. Behcet’s disease. Clin Exp Med 2004;4(1):10–20.

    Article  PubMed  CAS  Google Scholar 

  97. Pipitone N, Oliveri I, Cantini F, et al. New approaches in the treatment of Adamantiades-Behcet’s disease. Curr Opin Rheumatol 2006;18(1):3–9.

    Article  PubMed  CAS  Google Scholar 

  98. Guillevin L, Lhote F, Gallais V, et al. Gastro-intestinal tract involvement in polarteritis nodosa and Churg Straus syndrome. Ann Med Interne 1995;146: 260–267.

    CAS  Google Scholar 

  99. Hoffman G. Wegener’s granulomatosis. In: Klippel JL, Dieppe PA, eds. Rheumatology 2nd ed. Mosby, London, 1998, p. 7:22.4.

    Google Scholar 

  100. Harper L, Nuttall SL, Martin U, et al. Adjuvant treatment of patients with ANCA associated with vitamins E and C reduces superoxide production by neutrophils. Rheumatology 2002;41: 274–278.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Paul F. Dellaripa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donough Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Marshfield Clinic Research Foundation, Marshfield, WI

    Laura A. Coleman PhD, RD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Dellaripa, P.F., Howard, D. (2008). Nutritional Issues in Vasculitis. In: Coleman, L.A. (eds) Nutrition and Rheumatic Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-403-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-403-2_13

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-976-5

  • Online ISBN: 978-1-59745-403-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation